Can-Fite BioPharma Ltd. (TLV:CANF)

Can-Fite BioPharma Revenue

In the year 2025, Can-Fite BioPharma had annual revenue of $405.00K USD, down -39.91%. Can-Fite BioPharma had revenue of $203.00K in the half year ending December 31, 2025, a decrease of -42.17%.

• Revenue: $405.00K
• Revenue Growth: -39.91%
• P/S Ratio: 14.97
• Revenue / Employee: $81.00K
• Employees: 5
• Market Cap: 19.33M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	405.00K	-269.00K	-39.91%
Dec 31, 2024	674.00K	-69.00K	-9.29%
Dec 31, 2023	743.00K	-67.00K	-8.27%
Dec 31, 2022	810.00K	-43.00K	-5.04%
Dec 31, 2021	853.00K	90.00K	11.80%
Dec 31, 2020	763.00K	-1.27M	-62.45%
Dec 31, 2019	2.03M	-1.79M	-46.81%
Dec 31, 2018	3.82M	3.03M	384.16%
Dec 31, 2017	789.00K	624.00K	378.18%
Dec 31, 2016	165.00K	3.00K	1.85%
Dec 31, 2015	162.00K	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	467.66K	-278.63K	-37.34%
Dec 31, 2010	746.29K	-125.25K	-14.37%
Dec 31, 2009	871.53K	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 4, 2026

Data Sources Report a data error